Cargando…

Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats

Samchulkunbi-tang (SCT, Shen Zhu Jian pi tang in Chinese) is said to have been first recorded by Zheng Zhi Zhun Sheng during the Ming Dynasty in China. Records of SCT in Korea are known to have been cited in Donguibogam (Dong Yi Bao Jian in Chinese), Uibang Hwaltu (Yi Fang Huo Tao in Chinese), and B...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Mi Hyeon, Hwang, Jin Seok, Han, Byung Hyuk, Lee, Yun Jung, Yoon, Jung Joo, Seob Seo, Chang, Kang, Dae Gill, Kim, Hye Yoom, Lee, Ho Sub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709744/
https://www.ncbi.nlm.nih.gov/pubmed/34956385
http://dx.doi.org/10.1155/2021/8443952
_version_ 1784623009355530240
author Hong, Mi Hyeon
Hwang, Jin Seok
Han, Byung Hyuk
Lee, Yun Jung
Yoon, Jung Joo
Seob Seo, Chang
Kang, Dae Gill
Kim, Hye Yoom
Lee, Ho Sub
author_facet Hong, Mi Hyeon
Hwang, Jin Seok
Han, Byung Hyuk
Lee, Yun Jung
Yoon, Jung Joo
Seob Seo, Chang
Kang, Dae Gill
Kim, Hye Yoom
Lee, Ho Sub
author_sort Hong, Mi Hyeon
collection PubMed
description Samchulkunbi-tang (SCT, Shen Zhu Jian pi tang in Chinese) is said to have been first recorded by Zheng Zhi Zhun Sheng during the Ming Dynasty in China. Records of SCT in Korea are known to have been cited in Donguibogam (Dong Yi Bao Jian in Chinese), Uibang Hwaltu (Yi Fang Huo Tao in Chinese), and Bang Yak Hapyeon (Fang Yao He Bian in China). Although SCT is widely used in treating chronic gastritis and gastric ulcers, the beneficial effect on renal vascular function is unknown. Hypertension is a risk factor for cardiovascular disease and endothelial dysfunction in humans and experimental animal models of arterial hypertension. In addition, kidney dysfunction is characterized by hypertension diseases. This study was conducted to evaluate the effect of SCT on the vascular function in vitro (human umbilical cord endothelial cells, HUVECs) and in vivo (N(G)‐nitro‐L‐arginine methyl ester, L-NAME-induced hypertensive rats). The phosphorylation of protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS) is closely related to nitric oxide (NO) production in HUVECs, and SCT in this study significantly increased these. For three weeks, hypertensive rat models were induced by L-NAME administration (40 mg/kg/day) with portable water. It was followed by oral administration with 100 and 200 mg/kg/day for two weeks to confirm the effectiveness of SCT. As a result, systolic blood pressure decreased in the SCT-treated groups, compared with that in the L-NAME-induced hypertensive group. SCT treatment restored vasorelaxation by stimulating acetylcholine and cGMP production in the thoracic aorta. In addition, SCT treatment decreased intima-media thickness, attenuated the reduction of eNOS expression, and increased endothelin-1 expression. It also increased p-Akt and p-eNOS expression in hypertensive rat aorta. Furthermore, regarding renal function parameters, SCT ameliorated urine osmolality, urine albumin level, serum creatinine, and blood urea nitrogen levels. These results demonstrate that the oriental medicine SCT exerts potent vascular and renal protective effects on nitric oxide-deficient hypertensive rats and HUVECs
format Online
Article
Text
id pubmed-8709744
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87097442021-12-25 Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats Hong, Mi Hyeon Hwang, Jin Seok Han, Byung Hyuk Lee, Yun Jung Yoon, Jung Joo Seob Seo, Chang Kang, Dae Gill Kim, Hye Yoom Lee, Ho Sub Evid Based Complement Alternat Med Research Article Samchulkunbi-tang (SCT, Shen Zhu Jian pi tang in Chinese) is said to have been first recorded by Zheng Zhi Zhun Sheng during the Ming Dynasty in China. Records of SCT in Korea are known to have been cited in Donguibogam (Dong Yi Bao Jian in Chinese), Uibang Hwaltu (Yi Fang Huo Tao in Chinese), and Bang Yak Hapyeon (Fang Yao He Bian in China). Although SCT is widely used in treating chronic gastritis and gastric ulcers, the beneficial effect on renal vascular function is unknown. Hypertension is a risk factor for cardiovascular disease and endothelial dysfunction in humans and experimental animal models of arterial hypertension. In addition, kidney dysfunction is characterized by hypertension diseases. This study was conducted to evaluate the effect of SCT on the vascular function in vitro (human umbilical cord endothelial cells, HUVECs) and in vivo (N(G)‐nitro‐L‐arginine methyl ester, L-NAME-induced hypertensive rats). The phosphorylation of protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS) is closely related to nitric oxide (NO) production in HUVECs, and SCT in this study significantly increased these. For three weeks, hypertensive rat models were induced by L-NAME administration (40 mg/kg/day) with portable water. It was followed by oral administration with 100 and 200 mg/kg/day for two weeks to confirm the effectiveness of SCT. As a result, systolic blood pressure decreased in the SCT-treated groups, compared with that in the L-NAME-induced hypertensive group. SCT treatment restored vasorelaxation by stimulating acetylcholine and cGMP production in the thoracic aorta. In addition, SCT treatment decreased intima-media thickness, attenuated the reduction of eNOS expression, and increased endothelin-1 expression. It also increased p-Akt and p-eNOS expression in hypertensive rat aorta. Furthermore, regarding renal function parameters, SCT ameliorated urine osmolality, urine albumin level, serum creatinine, and blood urea nitrogen levels. These results demonstrate that the oriental medicine SCT exerts potent vascular and renal protective effects on nitric oxide-deficient hypertensive rats and HUVECs Hindawi 2021-12-17 /pmc/articles/PMC8709744/ /pubmed/34956385 http://dx.doi.org/10.1155/2021/8443952 Text en Copyright © 2021 Mi Hyeon Hong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hong, Mi Hyeon
Hwang, Jin Seok
Han, Byung Hyuk
Lee, Yun Jung
Yoon, Jung Joo
Seob Seo, Chang
Kang, Dae Gill
Kim, Hye Yoom
Lee, Ho Sub
Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats
title Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats
title_full Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats
title_fullStr Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats
title_full_unstemmed Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats
title_short Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats
title_sort samchulkunbi-tang alleviates vascular endothelial disorder and renal dysfunction in nitric oxide-deficient hypertensive rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709744/
https://www.ncbi.nlm.nih.gov/pubmed/34956385
http://dx.doi.org/10.1155/2021/8443952
work_keys_str_mv AT hongmihyeon samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats
AT hwangjinseok samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats
AT hanbyunghyuk samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats
AT leeyunjung samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats
AT yoonjungjoo samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats
AT seobseochang samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats
AT kangdaegill samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats
AT kimhyeyoom samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats
AT leehosub samchulkunbitangalleviatesvascularendothelialdisorderandrenaldysfunctioninnitricoxidedeficienthypertensiverats